Deciphering the Differences Between Epstein–Barr Virus‐Associated and Negative Gastric Cancer in the Prospect of CDKN2A Genomic Alterations and Lymphoid Infiltration
Cancer Medicine · 2025
DOI: 10.1002/cam4.70409 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Fuda Xie und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Sir Y.K. Pao Cancer Center, Prince of Wales Hospital…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Epstein-Barr Virus Infections, Herpesvirus 4, Human, Cyclin-Dependent Kinase Inhibitor p16. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Gastric cancer (GC) is a major health concern worldwide. One important contributing factor is the presence of the Epstein‐Barr virus (EBV). However, the molecular pattern of how EBV participates in the malignant transition process remains unclear.
Methods
GC samples were stained by immunohistochemistry, fluorescent and EBV‐encoded small RNA in situ hybridization to identify CD8 expression, CDKN2A genomic alteration, and EBV existence. Functional potentials of EBV infection were predicted by bioinformatic enrichment analysis.
Results
CDKN2A genestayed intact in all EBV‐associated GC cases. Meanwhile, CDKN2A deletion (8.43% cases) was exclusive to EBV‐negative GC cases. Furthermore, EBV infection was positively correlated with CD8+T cell infiltration, and both of them predicted better prognosis.
Conclusion
This study highlighted the comprehensive impact of EBV infection in GC formation and proposed a thought‐provoking observation for further investigation into the roles of CDKN2A and EBV infection in gastric tumorigenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Sir Y.K. Pao Cancer Center, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, SAR, China.
- Institute of Digestive Disease, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Science, The Chinese University of Hong Kong, Hong Kong, SAR, China.
- CUHK-Shenzhen Research Institute, Shenzhen, China.
- Department of Pediatrics, The Chinese University of Hong Kong, Hong Kong, SAR, China.
- Department of Hepatobiliary Surgery, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
- Department of Gastric Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
ORCID-Profile: Wei Kang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xie, F., Chen, B., Lyu, Y., Yu, P., Fang, C., Leung, K. T., Wang, S., Xu, D., Yu, J., Lo, K. W., To, K. F., & Kang, W. (2025). Deciphering the Differences Between Epstein–Barr Virus‐Associated and Negative Gastric Cancer in the Prospect of CDKN2A Genomic Alterations and Lymphoid Infiltration. Cancer Medicine. https://doi.org/10.1002/cam4.70409
Vancouver
Xie F, Chen B, Lyu Y, Yu P, Fang C, Leung KT, et al. Deciphering the Differences Between Epstein–Barr Virus‐Associated and Negative Gastric Cancer in the Prospect of CDKN2A Genomic Alterations and Lymphoid Infiltration. Cancer Medicine. 2025. doi:10.1002/cam4.70409
BibTeX
@article{Xie2025,
author = {Xie, Fuda and Chen, Bonan and Lyu, Yang and Yu, Peiyao and Fang, Canbin and Leung, Kam Tong and Wang, Shouyu and Xu, Dazhi and Yu, Jun and Lo, Kwok Wai and To, Ka Fai and Kang, Wei},
title = {Deciphering the Differences Between Epstein–Barr Virus‐Associated and Negative Gastric Cancer in the Prospect of CDKN2A Genomic Alterations and Lymphoid Infiltration},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.70409}
}
EUVIMED